| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |